The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Berman Robert Andrew since 2006.
This trader's CIK number is 1258360.
At the time of last reporting, Berman Robert Andrew was the Chief Executive Officer of Envveno Medical Corp. (stock ticker symbol NVNO).
Also see all insider trading activities at Envveno Medical Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | NVNO | 12,000 | $30,599 | 0 | $0 | 0 | $0 |
| 2022 | NVNO | 2,500 | $9,500 | 0 | $0 | 0 | $0 |
| 2021 | NVNO | 7,000 | $47,010 | 0 | $0 | 0 | $0 |
| 2019 | NVNO | 21,740 | $25,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | ACTG/CBMX | 0 | $0 | 7,661 | $114,915 | 7,661 | $30,007 |
| 2006 | ACTG/CBMX | 0 | $0 | 110,000 | $1,223,750 | 110,000 | $203,500 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | ITUS | 10,000 | $8,650 | 0 | $0 | 0 | $0 |
| 2015 | ITUS | 413,212 | $96,041 | 0 | $0 | 0 | $0 |
| 2014 | ITUS | 151,305 | $41,793 | 0 | $0 | 0 | $0 |
1. Envveno Medical Corp (NVNO)
2. Acacia Research Corp (ACTG/CBMX)
3. Anixa Biosciences Inc (ITUS)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-19 | NVNO | Buy | 12,000 | 2.55 | 30,599 |
| 2022-06-27 | NVNO | Buy | 2,500 | 3.80 | 9,500 |
| 2021-11-19 | NVNO | Buy | 2,000 | 7.43 | 14,860 |
| 2021-11-16 | NVNO | Buy | 2,000 | 7.87 | 15,740 |
| 2021-05-18 | HJLI | Buy | 3,000 | 5.47 | 16,410 |
| 2019-03-12 | HJLI | Buy | 21,740 | 1.15 | 25,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-02-09 | ACTG/CBMX | Option Ex | 2,100 | 3.92 | 8,225 |
| 2007-02-07 | ACTG/CBMX | Sale | 2,156 | 15.00 | 32,340 |
| 2007-02-08 | ACTG/CBMX | Option Ex | 3,405 | 3.92 | 13,337 |
| 2007-02-07 | ACTG/CBMX | Option Ex | 2,156 | 3.92 | 8,445 |
| 2007-02-09 | ACTG/CBMX | Sale | 2,100 | 15.00 | 31,500 |
| 2007-02-08 | ACTG/CBMX | Sale | 3,405 | 15.00 | 51,075 |
| 2006-05-02 | ACTG/CBMX | Option Ex | 27,500 | 1.85 | 50,875 |
| 2006-05-02 | ACTG/CBMX | Sale | 27,500 | 11.50 | 316,250 |
| 2006-04-26 | ACTG/CBMX | Option Ex | 55,000 | 1.85 | 101,750 |
| 2006-04-27 | ACTG/CBMX | Option Ex | 27,500 | 1.85 | 50,875 |
| 2006-04-26 | ACTG/CBMX | Sale | 55,000 | 10.88 | 598,125 |
| 2006-04-27 | ACTG/CBMX | Sale | 27,500 | 11.25 | 309,375 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-06-02 | ITUS | Buy | 10,000 | .86 | 8,650 |
| 2015-07-21 | ITUS | Buy | 5,000 | 5.77 | 28,849 |
| 2015-07-10 | ITUSD | Buy | 200 | 4.00 | 800 |
| 2015-07-07 | ITUSD | Buy | 200 | 3.80 | 760 |
| 2015-07-01 | ITUSD | Buy | 500 | 3.95 | 1,975 |
| 2015-06-30 | ITUSD | Buy | 600 | 3.75 | 2,250 |
| 2015-06-29 | ITUSD | Buy | 1,400 | 4.07 | 5,698 |
| 2015-06-26 | ITUSD | Buy | 312 | 5.00 | 1,560 |
| 2015-06-19 | ITUS | Buy | 20,000 | .14 | 2,800 |
| 2015-06-22 | ITUS | Buy | 60,000 | .15 | 9,000 |
| 2015-06-18 | ITUS | Buy | 50,000 | .13 | 6,500 |
| 2015-06-15 | ITUS | Buy | 30,000 | .14 | 4,080 |
| 2015-06-17 | ITUS | Buy | 50,000 | .14 | 6,750 |
| 2015-06-11 | ITUS | Buy | 25,000 | .14 | 3,549 |
| 2015-06-09 | ITUS | Buy | 10,000 | .14 | 1,400 |
| 2015-06-10 | ITUS | Buy | 10,000 | .14 | 1,450 |
| 2015-06-04 | ITUS | Buy | 20,000 | .16 | 3,260 |
| 2015-06-01 | ITUS | Buy | 30,000 | .14 | 4,260 |
| 2015-03-20 | ITUS | Buy | 50,000 | .10 | 5,000 |
| 2015-03-23 | ITUS | Buy | 50,000 | .12 | 6,100 |
| 2014-01-29 | COPY | Buy | 12,500 | .39 | 4,825 |
| 2014-01-27 | COPY | Buy | 39,500 | .30 | 12,008 |
| 2014-01-28 | COPY | Buy | 20,805 | .34 | 7,052 |
| 2014-01-24 | COPY | Buy | 8,500 | .30 | 2,533 |
| 2014-01-22 | COPY | Buy | 45,000 | .23 | 10,125 |
| 2014-01-21 | COPY | Buy | 25,000 | .21 | 5,250 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Berman Robert Andrew (Chief Executive Officer of Envveno Medical Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.